Literature DB >> 24158275

Differential diagnoses to MS: experiences from an optic neuritis clinic.

Henrik Horwitz1, Tina Friis, Signe Modvig, Hanne Roed, Anna Tsakiri, Bjarne Laursen, Jette Lautrup Frederiksen.   

Abstract

Optic neuritis (ON) is closely linked to multiple sclerosis (MS). It may, however, also be associated to a range of autoimmune or infectious diseases. The purpose of this study was to assess the differential diagnoses in patients with suspected ON. In this retrospective study, we reviewed the files of all patients referred to the Clinic of Optic Neuritis, Glostrup Hospital, University of Copenhagen, Denmark, between January 2000 and November 2011. All patients were referred by ophthalmologists with possible ON. Patients diagnosed with MS prior to referral were excluded from the study. A total of 643 patients were included in the study. Apart from ON, the most frequent diagnoses were tumors (n = 15), ischemic or hypertensive neuropathies (n = 13), and retinal or choroid disorders (n = 9). Six patients were diagnosed with neuromyelitis optica. Rarer causes of visual loss were infections (n = 5), giant cell arteritis (n = 4), sarcoidosis (n = 3), thyrotoxicosis (n = 2), and hereditary or toxic neuropathies (n = 2). Nine percent of patients referred to the Clinic of Optic Neuritis had symptoms caused by medical, neurosurgical or ophthalmic disorders, and 0.9 % of our patients had NMO. Though most of these conditions are rare, it is of importance to keep them in mind upon encountering patients with symptoms of ON.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24158275     DOI: 10.1007/s00415-013-7166-x

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  38 in total

1.  Acute optic neuritis and the prognosis for multiple sclerosis.

Authors:  W M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-03       Impact factor: 10.154

Review 2.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

Review 3.  The differential diagnosis of multiple sclerosis.

Authors:  Loren A Rolak; John O Fleming
Journal:  Neurologist       Date:  2007-03       Impact factor: 1.398

4.  Revised diagnostic criteria for neuromyelitis optica.

Authors:  D M Wingerchuk; V A Lennon; S J Pittock; C F Lucchinetti; B G Weinshenker
Journal:  Neurology       Date:  2006-05-23       Impact factor: 9.910

5.  Optic neuritis and ischemic optic neuropathy. Overlapping clinical profiles.

Authors:  J F Rizzo; S Lessell
Journal:  Arch Ophthalmol       Date:  1991-12

6.  Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: a prospective single-center study.

Authors:  Taxiarchis Felekis; Konstantinos Katsanos; Margarita Kitsanou; Nikolaos Trakos; Vasileios Theopistos; Dimitrios Christodoulou; Ioannis Asproudis; Epameinondas V Tsianos
Journal:  Inflamm Bowel Dis       Date:  2009-01       Impact factor: 5.325

Review 7.  Ischemic optic neuropathies.

Authors:  Janet C Rucker; Valérie Biousse; Nancy J Newman
Journal:  Curr Opin Neurol       Date:  2004-02       Impact factor: 5.710

8.  A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. The Optic Neuritis Study Group.

Authors:  R W Beck; P A Cleary; M M Anderson; J L Keltner; W T Shults; D I Kaufman; E G Buckley; J J Corbett; M J Kupersmith; N R Miller
Journal:  N Engl J Med       Date:  1992-02-27       Impact factor: 91.245

9.  Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica.

Authors:  Friedemann Paul; Sven Jarius; Orhan Aktas; Martin Bluthner; Oliver Bauer; Heribert Appelhans; Diego Franciotta; Roberto Bergamaschi; Edward Littleton; Jacqueline Palace; Hans-Peter Seelig; Reinhard Hohlfeld; Angela Vincent; Frauke Zipp
Journal:  PLoS Med       Date:  2007-04       Impact factor: 11.069

Review 10.  Management of acute optic neuritis.

Authors:  S J Hickman; C M Dalton; D H Miller; G T Plant
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

View more
  8 in total

1.  Optic neuritis caused by the re-emerging great masquerader.

Authors:  Nathanial S Nolan; Laura E Gibbons; Madihah A Hepburn; Ahmed Elkeeb; Hariharan Regunath
Journal:  BMJ Case Rep       Date:  2018-12-22

Review 2.  The Diagnosis and Treatment of Optic Neuritis.

Authors:  Helmut Wilhelm; Martin Schabet
Journal:  Dtsch Arztebl Int       Date:  2015-09-11       Impact factor: 5.594

3.  Incidence and Causes of Overdiagnosis of Optic Neuritis.

Authors:  Leanne Stunkel; Nathan H Kung; Bradley Wilson; Collin M McClelland; Gregory P Van Stavern
Journal:  JAMA Ophthalmol       Date:  2018-01-01       Impact factor: 7.389

Review 4.  Update on Optic Neuritis: An International View.

Authors:  Simon J Hickman; Axel Petzold
Journal:  Neuroophthalmology       Date:  2021-08-31

Review 5.  Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases.

Authors:  Marcos L Aranda; María Florencia González Fleitas; Hernán Dieguez; Agustina Iaquinandi; Pablo H Sande; Damián Dorfman; Ruth E Rosenstein
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

6.  Bilateral papillitis and vitritis as the initial ophthalmologic finding in a patient with complex medical history, leading to diagnosis of multisystem sarcoidosis.

Authors:  Caiyun You; Lina Ma; Stephen D Anesi
Journal:  Am J Ophthalmol Case Rep       Date:  2018-12-21

7.  Commentary.

Authors:  Henrik Horwitz
Journal:  J Neurosci Rural Pract       Date:  2014-10

8.  Retrobulbar optic neuropathy associated with sphenoid sinus mucormycosis.

Authors:  Tatsuhiko Sano; Zen Kobayashi; Ken Takaoka; Kiyobumi Ota; Iichiroh Onishi; Mihoko Iizuka; Hiroyuki Tomimitsu; Shuzo Shintani
Journal:  Neurol Clin Neurosci       Date:  2018-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.